In the pursuit of effective and safe weight loss treatments, one name stands out: semaglutide. This remarkable anti-obesity medication continues to make waves even years after its FDA approval in 2021.
Originally formulated as a diabetes medication in injectable form, semaglutide has evolved beyond its initial purpose. It now stands as a pivotal solution for chronic weight management, particularly for obese or overweight American adults. Research underscores the potency of semaglutide injections in facilitating weight loss and highlights the importance of addressing obesity as a chronic metabolic condition.
Semaglutide, belonging to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), plays a multifaceted role. It mimics the GLP-1 hormone released after meals, which triggers insulin production, effectively lowering blood sugar levels. Beyond its diabetes application, semaglutide's interaction with the brain's satiety centers curbs appetite and induces feelings of fullness. When combined with dietary adjustments and exercise, semaglutide becomes a catalyst for significant weight loss, reducing the risk of conditions such as cancer, diabetes, and heart disease.
Unlike many weight loss medications, semaglutide goes beyond appetite suppression. An initial study involving 2,000 obese adults compared those who incorporated semaglutide into their lifestyle with those who relied solely on diet and exercise changes. The results were striking – after 68 weeks, semaglutide users achieved a 15% reduction in body weight, with nearly a third experiencing a 20% loss. In contrast, lifestyle changes alone led to a mere 2.4% weight loss. Subsequent studies echoed these findings, solidifying semaglutide's efficacy.
Considering the potential complications of obesity, semaglutide's side effects are generally mild. These may include:
Most gastrointestinal issues arise with new users. By starting with a lower dose and gradually increasing it, these effects can be mitigated.
At Sariel Aesthetics, we ensure a thorough evaluation to determine your suitability for semaglutide treatment. FDA guidelines outline ideal candidates, while those with a history of certain conditions, including medullary thyroid cancer, gallbladder disease, pancreatitis, and multiple endocrine neoplasia syndrome type 2 (MEN2), should avoid semaglutide. Before embarking on your weight loss journey with semaglutide, consult with us or your Primary Care Physician. This step is crucial to assess your medical history and find the most fitting treatment, especially if you're already on diabetes medication.
You have the potential to begin a regimen that transforms your weight loss efforts, leading to a healthier, happier you. Our dedicated team at Sariel Aesthetics is committed to supporting you on this journey. Contact us today or schedule a consultation to discover more.
*Individual results are not guaranteed and may vary from person to person. Images may contain models.
New Patient Consultations will incur a fee of $75 which will be credited to their first treatment. Those New Patients consulting for the Sariel Slim Down Treatment will incur an initial consultation fee of $145. Please note that these Consultation Fees are non-refundable if cancellation is not given within 24 hours of set appointment.
Share On: